|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$724,380
|
$181,095
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$742,894
|
$111,434
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$222,537
|
$44,507
|
Wang, Ji Ming
|
CCR (NCI)
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$645
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$347,473
|
$104,242
|
Khan, Javed
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-09
|
$328,591
|
$328,591
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-12
|
$755,168
|
$7,552
|
Jaslowski, Anthony
|
ST. VINCENT HOSPITAL
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-23
|
$435,423
|
$8,708
|
LANGEVIN, ANNE-MARIE
|
UNIV OF TX HSC, SA
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$482,268
|
$24,113
|
Daar, Ira
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$597,349
|
$59,735
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$597,349
|
$29,867
|
Tessarollo, Lino
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIA BC 011121
|
$84,501
|
$25,350
|
Mackem, Susan
|
CCR (NCI)
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-08
|
$242,810
|
$242,810
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$515,383
|
$103,077
|
Thiele, Carol
|
CCR (NCI)
|
|
Radiological Physics Center
|
5U10CA010953-45
|
$2,786,631
|
$27,866
|
Followill, David
|
UT MD ANDERSON CANCER CTR
|
|
Quality Assurance Review Center
|
3U10CA029511-33S1
|
$1,946,959
|
$19,470
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$354,138
|
$24,790
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
|
ZIA BC 011168
|
$501,613
|
$25,081
|
Zhang, Ying
|
CCR (NCI)
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-04
|
$313,829
|
$78,457
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$277,514
|
$27,751
|
Thiele, Carol
|
CCR (NCI)
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$3,200
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$274
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Oklahoma CCOP
|
2U10CA045459-27
|
$424,982
|
$4,250
|
LOCKHART, JAMES
|
WARREN CANCER RESEARCH FOUNDATION
|
|
Ochsner Community Clinical Oncology Program
|
5U10CA035272-29
|
$563,756
|
$5,638
|
Fuloria, Jyotsna
|
OCHSNER CLINIC FOUNDATION
|
|
North Central Cancer Treatment Group
|
3U10CA025224-33S1
|
$5,872,026
|
$352,322
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
New Mexico Minority Based Community Clinical Oncology Program
|
2U10CA086780-14
|
$795,607
|
$7,956
|
ROYCE, MELANIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Nemours Community Clinical Oncology Program
|
1U10CA176879-01
|
$558,366
|
$5,584
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
3U54CA151880-04S1
|
$53,972
|
$3,238
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-04
|
$2,130,727
|
$127,844
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,252,979
|
$62,649
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$146,598
|
$51,309
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$115,824
|
$5,791
|
Khan, Javed
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$482,268
|
$48,227
|
Daar, Ira
|
CCR (NCI)
|
|
Mechanisms of ATM activation
|
5R01CA132813-05
|
$228,365
|
$228,365
|
PAULL, TANYA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Marshfield Clinic Community Clinical Oncology Program
|
2U10CA035412-30
|
$969,800
|
$9,698
|
WEISS, MATTHIAS
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
LSUHSC Minority-Based Community Clinical Oncology Program
|
5U10CA063845-15
|
$530,237
|
$5,302
|
VEITH, ROBERT
|
LSU HEALTH SCIENCES CENTER
|
|
Iowa Womens Health Study Drinking Water Nitrate Analysis
|
ZIA CP010125-10347
|
$25,617
|
$2,562
|
Ward, Mary
|
DCEG (NCI)
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
$7,476
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,388,882
|
$55,555
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$949,760
|
$47,488
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$513,092
|
$51,309
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Gundersen Lutheran Proposal to Join the Community Clinical Oncology Program
|
5U10CA159950-03
|
$445,370
|
$4,454
|
Oettel, Kurt
|
GUNDERSEN LUTHERAN MEDICAL FOUNDATION
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
5U10CA107586-10
|
$480,324
|
$4,803
|
Ghamande, Sharad
|
GEORGIA REGENTS UNIVERSITY
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$630,367
|
$31,518
|
Gottesman, Michael
|
CCR (NCI)
|
|
Geisinger Clinical Oncology Program
|
3U10CA035448-29S1
|
$498,395
|
$4,984
|
Gorak, Edward
|
GEISINGER CLINIC
|
|
FEN-1 and PCNA Complexes and Human Genome Stability
|
5R01CA081967-14
|
$320,242
|
$160,121
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy
|
ZIA BC 010709
|
$73,556
|
$7,356
|
Warren, Katherine
|
CCR (NCI)
|
|
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
|
5R01CA164295-02
|
$269,641
|
$134,821
|
Karajannis, Matthias
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
EORTC HEADQUARTERS
|
4U10CA011488-43
|
$250,025
|
$2,500
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
ECOG Statistical Office Data Management Grant
|
5U10CA066636-20
|
$2,152,030
|
$43,041
|
GRAY, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
Total relevant funding to Central Nervous System - Not Including Brain for this search: $5,586,606
|